GlobeNewswire Inc.··NaDyne Therapeutics to Showcase Neuromuscular Pipeline Progress at MDA 2026 Conference
Dyne Therapeutics will present five neuromuscular disease presentations at MDA 2026, showcasing cardiopulmonary data from DMD trial and Phase 3 design for myotonic dystrophy treatment.
DYNclinical trialDyne Therapeutics